Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 43, Issue 6

Issues

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Katharina Pachmann / Joachim H. Clement / Claus-Peter Schneider / Babette Willen / Oumar Camara / Ulrich Pachmann / Klaus Höffken
Published Online: 2014-06-11 | DOI: https://doi.org/10.1515/CCLM.2005.107

Abstract

Detection and quantitation of circulating tumor cells from solid epithelial tumors could become a valuable tool for therapy monitoring if the procedure can be standardized. In the present work we assessed the influence of preanalytical handling, storage and white blood cell isolation on analysis of a population of spiked tumor cell-line cells and intrinsically present epithelial cells in the peripheral blood of breast and lung cancer patients and the sensitivity of their detection. Sucrose density separation did not enrich epithelial cells, and even depleted them, leading to a gross underestimation of their numbers (3/13 positive, between 2.9 and 50cells/mL) in comparison to red blood cell lysis (13/13 positive, between 77,200 and 800cells/mL). Short-term storage of whole blood samples for up to 7days had little influence on the number of epithelial cells recovered. The effectiveness of magnetic bead enrichment was dependent on the number of relevant cells and the volume used for enrichment. Red blood cell lysis and fluorochrome-labeled antibody staining in a no-wash procedure with subsequent laser scanning cytometry allowed the detection of circulating epithelial cells in 92% of breast and lung cancer patients. Two examples of how this method can be applied for the longitudinal analysis in individual patients are shown, with an increase in numbers preceding relapse and a decrease paralleling tumor reduction. The proposed simple and easy method allows close monitoring, which may help in real-time analysis of the response of solid tumors, especially their systemic component, to therapy and hopefully will contribute to more individually tailored therapy.

Keywords: circulating tumor cells; standardization; therapy monitoring.

References

  • 1

    Gross HJ, Verwer B, Houck D, Hoffman RA, Recktenwald D. Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10 –7. Proc Natl Acad Sci USA 1995; 92: 537–41. CrossrefGoogle Scholar

  • 2

    Riethmueller G, Schlimok G, Kufer P, Gruber R, Holz E, Pantel K. Minimal residual disease in solid cancer: the diagnostic and therapeutic opportunity for monoclonal antibodies. Ann Oncol 1996; 7(Suppl 1): 17. Google Scholar

  • 3

    Ghossein RA, Rossai J. Polymerase chain reaction in the detection of micrometastases and circulating tumour cells. Cancer 1996; 78: 10–6. CrossrefGoogle Scholar

  • 4

    Ross AA. Minimal residual disease in solid tumour malignancies: a review. J Hematother 1998; 7: 9–18. CrossrefGoogle Scholar

  • 5

    Pantel K, von Knebel Doeberitz M, Izbicki JR, Riethmüller G. Disseminierte Tumorzellen: Diagnostik, prognostische Relevanz, Phänotypisierung und therapeutische Strategien. Chirurg 1997; 68: 1241–50. CrossrefGoogle Scholar

  • 6

    Bessa X, Elizalde JI, Boix L, Pinol V, Lacy AM, Salo J, et al. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. Gastroenterology 2001; 120: 1084–92. CrossrefGoogle Scholar

  • 7

    Moldenhauer G, Momburg F, Moller P, Schwartz R, Hammerling GJ. Epithelium-specific surface glycoprotein of M r 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987; 56: 714–21. Google Scholar

  • 8

    Pachmann K, Heiß P, Demel U, Tilz G. Detection and quantification of small numbers of circulating tumor cells in peripheral blood using Laser Scanning Cytometry (LSC ®). Clin Chem Lab Med 2001; 39: 811–7. CrossrefGoogle Scholar

  • 9

    Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, et al. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991; 27: 1461–5. CrossrefGoogle Scholar

  • 10

    Thorban S, Rosenberg R, Busch R, Roeder RJ. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 2000; 83: 35–9. Google Scholar

  • 11

    Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A, et al. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol 1999; 112: 171–8. CrossrefGoogle Scholar

  • 12

    Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich C, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000; 342: 526–33. Google Scholar

  • 13

    Liotta LA, Kleinermann J, Sidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34: 997–1004. Google Scholar

  • 14

    Baran J, Pituch-Noworolska A, Krzezowiak A, Wieckiewicz J, Stachura J, Pryjma J, et al. Detection of cancer cells in the blood by FACS sorting of CD45 cells. Int J Mol Med 1998; 1: 573–8. Google Scholar

  • 15

    Pantel K, Felber E, Schlimok G. Detection and characterization of residual disease in breast cancer. J Hematother 1994; 3: 315–22. CrossrefGoogle Scholar

  • 16

    Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 1996; 88: 1652–8. CrossrefGoogle Scholar

  • 17

    Lilleng PK, Harveit F. Missed micrometastases – the extent of the problem. Acta Oncol 2000; 39: 313–7. CrossrefGoogle Scholar

  • 18

    Nakamura T, Yasamura T, Hayashi K, Educhi R, Ide H, Takasaki K, et al. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation. Anticancer Res 2000; 20: 4739–44. Google Scholar

  • 19

    Weitz J, Kienle P, Magener A, Koch M, Schrodel A, Willeke F, et al. Detection of disseminated colorectal cancer cells in lymph nodes blood and bone marrow. Clin Cancer Res 1999; 5: 1830–6. Google Scholar

  • 20

    Lopez-Guerrero JA, Gilabert PB, Gonzalez EB, Sanz Alonso MA, Perez JP, Talens AS, et al. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19 and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry. J Hematother 1999; 8: 53–61. CrossrefGoogle Scholar

  • 21

    Jung R, Petersen K, Krueger W, Wolf M, Wagener C, Zander A, et al. Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Br J Cancer 1999; 81: 870–3. CrossrefGoogle Scholar

  • 22

    Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998; 95: 4589–9. CrossrefGoogle Scholar

  • 23

    Fodstad O, Faye R, Hoifodt HK, Skovlund E, Aamdal S. Immunobead based detection and characterization of circulating tumor cells in melanoma patients. Recent Results Cancer Res 2001; 158: 40–50. Google Scholar

  • 24

    Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H, Meye A. Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 2001; 92: 577–82. CrossrefGoogle Scholar

  • 25

    Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668–73. CrossrefGoogle Scholar

  • 26

    des Guetz G, Lacortes JM, Camilleri-Broet S, Bouillot JL, de Mestier P. Micrometastases in colonic cancers: diagnostic methods and prognostic elements. J Chir 2002; 139: 141–8. Google Scholar

  • 27

    von Knebel-Doeberitz M, Koch M, Weitz J, Herfarth C. Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma. Zentralbl Chir 2000; 125(Suppl 1): 15–9. Google Scholar

  • 28

    Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology. Ann Thorac Surg 2002; 74: 278–84. CrossrefGoogle Scholar

  • 29

    Tsavellas G, Patel H, Allen-Mersh TG. Detection and significance of occult tumor cells in colorectal cancer. Br J Surg 2001; 88: 1307–20. CrossrefGoogle Scholar

  • 30

    Iorgulescu DG, Kiroff GK. Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow. ANZ J Surg 2001; 71: 365–76. CrossrefGoogle Scholar

  • 31

    Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Öhl S, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998; 26: 252–64. Google Scholar

  • 32

    Krag DN, Ashikaga T, Moss TJ, Kusminsky RE, Feldman S, Carp NZ, et al. Breast cancer cells in the blood: a pilot study. Breast J 1999; 5: 354–58. CrossrefGoogle Scholar

  • 33

    Iinuma H, Okinaga K, Adachi M, Suda K, Sekine T, Sakagawa K, et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and k-ras gene in patients with colorectal cancer. Int J Cancer 2000; 89: 337–44. Google Scholar

  • 34

    Siewert C, Herber M, Hunzelmann N, Fodstad O, Miltenyi S, Assenmacher M, et al. Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining. Recent Results Cancer Res 2001; 158: 51–60. Google Scholar

  • 35

    Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J Urol 2003; 169: 701–5. Google Scholar

  • 36

    Tsavellas G, Huang A, McCullough T, Patel H, Araia R, Allen-Mersh TG. Flow cytometry correlates with RT-PCR for detection of spiked but not circulating colorectal cancer cells. Clin Exp Metastasis 2002; 19: 495–502. CrossrefGoogle Scholar

  • 37

    Bertau P, Dumas F, Gala J-L, Eschwege P, Laour B, Philippe M, et al. Molecular detection of circulating prostate cells in cancer II: comparison of prostate epithelial cell isolation procedures. Clin Chem 1998; 44: 1750–3. Google Scholar

  • 38

    Benez A, Geiselhart A, Handgretinger R, Schiebel U, Fierlbeck G. Detection of circulating melanoma cells by immunomagnetic cell sorting. J Clin Lab Anal 1999; 13: 229–33. CrossrefGoogle Scholar

  • 39

    Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 2003; 162: 149–55. Google Scholar

  • 40

    Vlems FA, Ladanyi A, Gertler R, Rosenberg R, Diepstra JH, Roder C, et al. Reliability of quantitative reverse-transcriptase-PCR-based detection of tumour cells in the blood between different laboratories using a standardised protocol. Eur J Cancer 2003; 39: 388–96. CrossrefGoogle Scholar

  • 41

    Schamhart D, Swinnen J, Kurth KH, Westerhof A, Kusters R, Borchers H, et al. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin asevaluated for prostate cancer cells. Clin Chem 2003; 49: 1458–66. CrossrefGoogle Scholar

About the article

Corresponding author: Katharina Pachmann, Abteilung für Experimentelle Hämatologie und Onkologie der Klinik für Innere Medizin II der Friedrich Schiller Universität Jena, Erlanger Allee 101, 07747 Jena, Germany Phone: +49-3641-9325821, Fax: +49-3641-9325827,


Received: 2004-11-30

Accepted: 2005-04-20

Published Online: 2014-06-11

Published in Print: 2005-06-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 43, Issue 6, Pages 617–627, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.107.

Export Citation

© Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Monika Pizon, Daniel Lux, Ulrich Pachmann, Katharina Pachmann, and Dorothea Schott
Journal of Translational Medicine, 2018, Volume 16, Number 1
[2]
[4]
Yu-Chao Ma, Li Wang, and Feng-Lei Yu
Technology in Cancer Research & Treatment, 2013, Volume 12, Number 4, Page 295
[5]
Katharina Pachmann, Oumar Camara, Andreas Kavallaris, Uwe Schneider, Stefanie Schünemann, and Klaus Höffken
Breast Cancer Research, 2005, Volume 7, Number 6
[7]
Long R. Jiao, Christos Apostolopoulos, Jimmy Jacob, Richard Szydlo, Natalia Johnson, Nicole Tsim, Nagy A. Habib, R. Charles Coombes, and Justin Stebbing
Journal of Clinical Oncology, 2009, Volume 27, Number 36, Page 6160
[8]
Katharina Pachmann
Journal of Clinical Oncology, 2008, Volume 26, Number 21, Page 3657
[9]
Katharina Pachmann, Oumar Camara, Andreas Kavallaris, Sabine Krauspe, Nele Malarski, Mieczyslaw Gajda, Torsten Kroll, Cornelia Jörke, Ulrike Hammer, Annelore Altendorf-Hofmann, Carola Rabenstein, Ulrich Pachmann, Ingo Runnebaum, and Klaus Höffken
Journal of Clinical Oncology, 2008, Volume 26, Number 8, Page 1208
[10]
Michail Ignatiadis, Françoise Rothé, Carole Chaboteaux, Virginie Durbecq, Ghizlane Rouas, Carmen Criscitiello, Jessica Metallo, Naima Kheddoumi, Sandeep K. Singhal, Stefan Michiels, Isabelle Veys, José Rossari, Denis Larsimont, Birgit Carly, Marta Pestrin, Silvia Bessi, Frédéric Buxant, Fabienne Liebens, Martine Piccart, Christos Sotiriou, and Syed A. Aziz
PLoS ONE, 2011, Volume 6, Number 1, Page e15624
[11]
Jiatao Lou, Suqin Ben, Guohua Yang, Xiaohui Liang, Xiaoqian Wang, Songshi Ni, Baohui Han, and John D. Minna
PLoS ONE, 2013, Volume 8, Number 12, Page e80458
[12]
Carolyn G. Marsden, Mary Jo Wright, Latonya Carrier, Krzysztof Moroz, Brian G. Rowan, and Pranela Rameshwar
PLoS ONE, 2012, Volume 7, Number 11, Page e47587
[13]
Farhad Khosravi, Patrick J Trainor, Christopher Lambert, Goetz Kloecker, Eric Wickstrom, Shesh N Rai, and Balaji Panchapakesan
Nanotechnology, 2016, Volume 27, Number 44, Page 44LT03
[14]
[15]
Farhad Khosravi, Benjamin King, Sesh Rai, Goetz Kloecker, Eric Wickstrom, and Balaji Panchapakesan
IEEE Nanotechnology Magazine, 2013, Volume 7, Number 4, Page 20
[16]
Y. C. Lim and A. P. Wiegmans
Medical Oncology, 2016, Volume 33, Number 4
[17]
Majid Ebrahimi Warkiani, Bee Luan Khoo, Lidan Wu, Andy Kah Ping Tay, Ali Asgar S Bhagat, Jongyoon Han, and Chwee Teck Lim
Nature Protocols, 2015, Volume 11, Number 1, Page 134
[18]
Jeffrey B. Smerage and Daniel F. Hayes
Cancer Investigation, 2008, Volume 26, Number 2, Page 109
[19]
Chuanli Ren, Chongxu Han, Deyuan Fu, Daxin Wang, Hui Chen, Yong Chen, and Ming Shen
International Journal of Cancer, 2016, Volume 138, Number 7, Page 1586
[20]
Katharina Pachmann
Expert Review of Molecular Diagnostics, 2015, Volume 15, Number 5, Page 597
[21]
Nadine Rudiger, Ernst-Ludwig Stein, Erika Schill, Gabriele Spitz, Carola Rabenstein, Martina Stauch, Matthias Rengsberger, Ingo B. Runnebaum, Ulrich Pachmann, and Katharina Pachmann
Journal of Cancer Therapy, 2013, Volume 04, Number 02, Page 597
[22]
May El Sherif, Claus Peter Schneider, Carola Rabenstein, Amina Hessein Hassab, Magdy Mamdouh El Bordiny, Mona Wagdy Ayad, and Katharina Pachmann
Advances in Lung Cancer, 2013, Volume 02, Number 01, Page 1
[23]
Sarah Sorg, Katharina Pachmann, Katya Brede-Hekimian, Martin Freesmeyer, and Thomas Winkens
Cancer Letters, 2015, Volume 356, Number 2, Page 491
[24]
David T. Miyamoto, Lecia V. Sequist, and Richard J. Lee
Nature Reviews Clinical Oncology, 2014, Volume 11, Number 7, Page 401
[25]
Ute Neugebauer, Christian Kurz, Thomas Bocklitz, Tina Berger, Thomas Velten, Joachim Clement, Christoph Krafft, and Jürgen Popp
Micromachines, 2014, Volume 5, Number 2, Page 204
[26]
Xiangjun Zheng, Linan Jiang, Joyce Schroeder, Alison Stopeck, and Yitshak Zohar
Biomicrofluidics, 2014, Volume 8, Number 2, Page 024119
[27]
[28]
Daniel L. Adams, Peixuan Zhu, Olga V. Makarova, Stuart S. Martin, Monica Charpentier, Saranya Chumsri, Shuhong Li, Platte Amstutz, and Cha-Mei Tang
RSC Adv., 2014, Volume 4, Number 9, Page 4334
[29]
Hadi Esmaeilsabzali, Timothy V. Beischlag, Michael E. Cox, Ash M. Parameswaran, and Edward J. Park
Biotechnology Advances, 2013, Volume 31, Number 7, Page 1063
[30]
Vincenza Conteduca, Rita Zamarchi, Elisabetta Rossi, Valentina Condelli, Laura Troiani, and Michele Aieta
Future Oncology, 2013, Volume 9, Number 9, Page 1337
[31]
Sunil K. Arya, Bing Lim, and Abdur Rub Abdur Rahman
Lab on a Chip, 2013, Volume 13, Number 11, Page 1995
[32]
Fu-Rong Li, Qing Li, Han-Xin Zhou, Hui Qi, and Chun-Yan Deng
Nanomedicine: Nanotechnology, Biology and Medicine, 2013, Volume 9, Number 7, Page 1106
[33]
Rosa Nadal, José Antonio Lorente, Rafael Rosell, and María Jose Serrano
Expert Review of Molecular Diagnostics, 2013, Volume 13, Number 3, Page 295
[34]
Seonyoung Kim, Song-I Han, Min-Jae Park, Chang-Wan Jeon, Young-Don Joo, In-Hak Choi, and Ki-Ho Han
Analytical Chemistry, 2013, Volume 85, Number 5, Page 2779
[35]
T. Winkens, K. Pachmann, and M. Freesmeyer
Nuklearmedizin, 2012, Volume 52, Number 1, Page 7
[36]
Franck Chiappini
International Journal of Hepatology, 2012, Volume 2012, Page 1
[37]
Sabine Riethdorf and Klaus Pantel
Breast Cancer Research, 2009, Volume 11, Number S3
[38]
Andrew D. Hughes and Michael R. King
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2012, Volume 4, Number 3, Page 291
[39]
Evi S. Lianidou and Athina Markou
Laboratory Medicine Online, 2012, Volume 2, Number 2, Page 59
[40]
Marco Danova, Martina Torchio, and Giuliano Mazzini
Expert Review of Molecular Diagnostics, 2011, Volume 11, Number 5, Page 473
[41]
Katya Hekimian, Sandra Meisezahl, Kristin Trompelt, Carola Rabenstein, and Katharina Pachmann
ISRN Oncology, 2012, Volume 2012, Page 1
[42]
Marco Wendel, Lyudmila Bazhenova, Rogier Boshuizen, Anand Kolatkar, Meghana Honnatti, Edward H Cho, Dena Marrinucci, Ajay Sandhu, Anthony Perricone, Patricia Thistlethwaite, Kelly Bethel, Jorge Nieva, Michel van den Heuvel, and Peter Kuhn
Physical Biology, 2012, Volume 9, Number 1, Page 016005
[43]
Katya Hekimian, Ernst-Ludwig Stein, Ulrich Pachmann, and Katharina Pachmann
Clinical Chemistry and Laboratory Medicine, 2012, Volume 50, Number 4
[44]
Kurt Lobodasch, Frank Fröhlich, Matthias Rengsberger, Rene Schubert, Robert Dengler, Ulrich Pachmann, and Katharina Pachmann
The Breast, 2007, Volume 16, Number 2, Page 211
[45]
Evi S. Lianidou and Athina Markou
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 10
[46]
Adrianos Nezos, Nikolaos Pissimisis, Peter Lembessis, Antigone Sourla, Peter Dimopoulos, Theodore Dimopoulos, Kostantinos Tzelepis, and Michael Koutsilieris
Cancer Treatment Reviews, 2009, Volume 35, Number 3, Page 272
[47]
Bianca Mostert, Stefan Sleijfer, John A. Foekens, and Jan Willem Gratama
Cancer Treatment Reviews, 2009, Volume 35, Number 5, Page 463
[49]
Katharina Pachmann, O. Camara, T. Kroll, M. Gajda, A. K. Gellner, J. Wotschadlo, and I. B. Runnebaum
Journal of Cancer Research and Clinical Oncology, 2011, Volume 137, Number 9, Page 1317
[50]
Holly Graves and Brian J. Czerniecki
Pathology Research International, 2011, Volume 2011, Page 1
[51]
Marianna Alunni-Fabbroni and Maria Teresa Sandri
Methods, 2010, Volume 50, Number 4, Page 289
[52]
Volkmar Müller, Catherine Alix-Panabières, and Klaus Pantel
European Journal of Cancer, 2010, Volume 46, Number 7, Page 1189
[53]
Michail Ignatiadis, Vassilis Georgoulias, and Dimitris Mavroudis
European Journal of Cancer, 2008, Volume 44, Number 18, Page 2726
[54]
Yao-Kuang Chung, Julien Reboud, Kok Chuan Lee, Hui Min Lim, Pei Yi Lim, Karen Yanping Wang, Kum Cheong Tang, HongMiao Ji, and Yu Chen
Biosensors and Bioelectronics, 2011, Volume 26, Number 5, Page 2520
[55]
Katharina Pachmann, Oumar Camara, Annika Kohlhase, Carola Rabenstein, Torsten Kroll, Ingo B. Runnebaum, and Klaus Hoeffken
Journal of Cancer Research and Clinical Oncology, 2011, Volume 137, Number 5, Page 821
[56]
Andrianos Nezos, Pavlos Msaouel, Nikolaos Pissimissis, Peter Lembessis, Antigone Sourla, Athanasios Armakolas, Helen Gogas, Alexandros J. Stratigos, Andreas D. Katsambas, and Michael Koutsilieris
Cancer Treatment Reviews, 2011, Volume 37, Number 4, Page 284
[57]
Sebastian Dochow, Christoph Krafft, Ute Neugebauer, Thomas Bocklitz, Thomas Henkel, Günter Mayer, Jens Albert, and Jürgen Popp
Lab on a Chip, 2011, Volume 11, Number 8, Page 1484
[58]
R. KAUFMANN, P. MÜLLER, G. HILDENBRAND, M. HAUSMANN, and C. CREMER
Journal of Microscopy, 2011, Volume 242, Number 1, Page 46
[59]
Min Yu, Shannon Stott, Mehmet Toner, Shyamala Maheswaran, and Daniel A. Haber
The Journal of Cell Biology, 2011, Volume 192, Number 3, Page 373
[60]
M. Schwalbe, N. Buske, M. Vetterlein, K. Höffken, K. Pachmann, and J. H. Clement
Zeitschrift für Physikalische Chemie, 2006, Volume 220, Number 1_2006, Page 125
[61]
Satvinder Mudan, Alexandros Giakoustidis, Andrew V Thillainayagam, Jimmy Jacob, and Justin Stebbing
Future Oncology, 2010, Volume 6, Number 1, Page 177
[62]
Jacqui A Shaw, James Brown, R Charles Coombes, Jimmy Jacob, Rachel Payne, Belinda Lee, Karen Page, Natasha Hava, and Justin Stebbing
Biomarkers in Medicine, 2011, Volume 5, Number 1, Page 87
[63]
U. Neugebauer, T. Bocklitz, J. H. Clement, C. Krafft, and J. Popp
The Analyst, 2010, Volume 135, Number 12, Page 3178
[64]
D. Mavroudis
Annals of Oncology, 2010, Volume 21, Number Supplement 7, Page vii95
[65]
Sabine Riethdorf and Klaus Pantel
Annals of the New York Academy of Sciences, 2010, Volume 1210, Number 1, Page 66
[66]
Carmen Criscitiello, Christos Sotiriou, and Michail Ignatiadis
Current Opinion in Oncology, 2010, Volume 22, Number 6, Page 552
[67]
Hiroya Takeuchi and Yuko Kitagawa
Journal of Hepato-Biliary-Pancreatic Sciences, 2010, Volume 17, Number 5, Page 577
[68]
Ute Neugebauer, Joachim H. Clement, Thomas Bocklitz, Christoph Krafft, and Jürgen Popp
Journal of Biophotonics, 2010, Volume 3, Number 8-9, Page 579
[69]
Seung Il Kim and Hyo-il Jung
Journal of Breast Cancer, 2010, Volume 13, Number 2, Page 125
[70]
Andreas O. H. Gerstner, Wiebke Laffers, and Attila Tárnok
Journal of Biophotonics, 2009, Volume 2, Number 8-9, Page 463
[71]
Oumar Camara, Cornelia Jörke, Ulrike Hammer, Anne Egbe, Carola Rabenstein, Ingo B. Runnebaum, Klaus Hoeffken, and Katharina Pachmann
Journal of Cancer Research and Clinical Oncology, 2009, Volume 135, Number 4, Page 643
[72]
Joan Manel Gasent Blesa, Vicente Alberola Candel, Emilio Esteban González, José Vidal Martínez, Rafael Gisbert Criado, Mariano Provencio Pulla, Juan Laforga Canales, and Katharina Pachmann
Clinical and Translational Oncology, 2008, Volume 10, Number 7, Page 399
[73]
Sabine Riethdorf, Harriet Wikman, and Klaus Pantel
International Journal of Cancer, 2008, Volume 123, Number 9, Page 1991
[74]
James M Reuben, Savitri Krishnamurthy, Wendy Woodward, and Massimo Cristofanilli
Expert Opinion on Medical Diagnostics, 2008, Volume 2, Number 4, Page 339
[75]
Ming Jian Ge, De Shi, Qing Chen Wu, Mei Wang, and Liang Bin Li
Journal of Cancer Research and Clinical Oncology, 2006, Volume 132, Number 4, Page 248

Comments (0)

Please log in or register to comment.
Log in